Clinical Trial Update: Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating topical rapamycin (sirolimus) for complicated vascular anomalies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Anomaly

Drugs mentioned

• Rapamycin (sirolimus) topical (sirolimus)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Vascular Anomaly | Phase 1 | Status: TERMINATED